| Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC) CM Robb, JI Contreras, S Kour, MA Taylor, M Abid, YA Sonawane, ... Chemical communications 53 (54), 7577-7580, 2017 | 208 | 2017 |
| Cyclin dependent kinase 9 inhibitors for cancer therapy: miniperspective YA Sonawane, MA Taylor, JV Napoleon, S Rana, JI Contreras, ... Journal of medicinal chemistry 59 (19), 8667-8684, 2016 | 142 | 2016 |
| Synthesis and anti-breast cancer activities of substituted quinolines A Shi, TA Nguyen, SK Battina, S Rana, DJ Takemoto, PK Chiang, DH Hua Bioorganic & medicinal chemistry letters 18 (11), 3364-3368, 2008 | 115 | 2008 |
| Selective degradation of CDK6 by a palbociclib based PROTAC S Rana, M Bendjennat, S Kour, HM King, S Kizhake, M Zahid, ... Bioorganic & medicinal chemistry letters 29 (11), 1375-1379, 2019 | 112 | 2019 |
| Inhibition of Alzheimer’s amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo HS Hong, S Rana, L Barrigan, A Shi, Y Zhang, F Zhou, LW Jin, DH Hua Journal of neurochemistry 108 (4), 1097-1108, 2009 | 103 | 2009 |
| Isatin derived spirocyclic analogues with α-methylene-γ-butyrolactone as anticancer agents: a structure–activity relationship study S Rana, EC Blowers, C Tebbe, JI Contreras, P Radhakrishnan, S Kizhake, ... Journal of medicinal chemistry 59 (10), 5121-5127, 2016 | 97 | 2016 |
| A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid‐β oligomeric complexes I Maezawa, HS Hong, HC Wu, SK Battina, S Rana, T Iwamoto, GA Radke, ... Journal of neurochemistry 98 (1), 57-67, 2006 | 92 | 2006 |
| Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced … HS Hong, I Maezawa, N Yao, B Xu, R Diaz-Avalos, S Rana, DH Hua, ... Brain research 1130, 223-234, 2007 | 85 | 2007 |
| Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases S Rana, EC Blowers, A Natarajan Journal of medicinal chemistry 58 (1), 2-29, 2015 | 71 | 2015 |
| Micellar formulation of indocyanine green for phototherapy of melanoma V Mundra, Y Peng, S Rana, A Natarajan, RI Mahato Journal of Controlled Release 220, 130-140, 2015 | 57 | 2015 |
| Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases YP Pang, F Ekström, GA Polsinelli, Y Gao, S Rana, DH Hua, B Andersson, ... PLoS One 4 (8), e6851, 2009 | 43 | 2009 |
| Novel Selective and Irreversible Mosquito Acetylcholinesterase Inhibitors for Controlling Malaria and Other Mosquito-Borne Diseases HJYPP Dengfeng Dou, Jewn Giew Park, Sandeep Rana Nature Scientific Reports 3, 1068, 2013 | 40* | 2013 |
| Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax HM King, S Rana, SP Kubica, JR Mallareddy, S Kizhake, EL Ezell, ... Bioorganic & medicinal chemistry letters 43, 128061, 2021 | 37 | 2021 |
| Face selective reduction of the exocyclic double bond in isatin derived spirocyclic lactones S Rana, A Natarajan Org. Biomol. Chem. 11 (2), 244-247, 2013 | 37 | 2013 |
| Candidate anti-Aβ fluorene compounds selected from analogs of amyloid imaging agents HS Hong, I Maezawa, M Budamagunta, S Rana, A Shi, R Vassar, R Liu, ... Neurobiology of aging 31 (10), 1690-1699, 2010 | 36 | 2010 |
| Synthesis and SAR studies of novel 1, 2, 4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy F Shamsi, P Hasan, A Queen, A Hussain, P Khan, B Zeya, HM King, ... Bioorganic Chemistry 98, 103754, 2020 | 35 | 2020 |
| Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase T Chen, K Takrouri, S Hee-Hwang, S Rana, R Yefidoff-Freedman, ... Journal of medicinal chemistry 56 (23), 9457-9470, 2013 | 32 | 2013 |
| Combination of nanogel polyethylene glycol-polyethylenimine and 6 (hydroxymethyl)-1, 4-anthracenedione as an anticancer nanomedicine C Ganta, A Shi, SK Battina, M Pyle, S Rana, DH Hua, M Tamura, D Troyer Journal of nanoscience and nanotechnology 8 (5), 2334-2340, 2008 | 30 | 2008 |
| Characterization of CDK (5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy CM Robb, S Kour, JI Contreras, E Agarwal, CJ Barger, S Rana, ... Oncotarget 9 (4), 5216, 2018 | 29 | 2018 |
| PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells AS Balawant Kumar, Rizwan Ahmad, Swagat Sharma, Saiprasad Gowrikumar, Mark ... Cancers 13 (9), 2168, 2021 | 27 | 2021 |
Amar NatarajanProfessor, University of Nebraska Medical CenterVerified email at unmc.edu
